Basic Information
| RNALocate ID: | RLID:11001408 |
| RNA Symbol: | hsa-miR-181a-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-181a |
| RNA ID: | miRBase:MIMAT0000256 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 22116803 |
| Tissue/Cell Line: | Ovarian follicular fluid |
| Method: | Flow cytometry|qPCR|Transmission electron microscopy |
| Description: | Exosomal miRNAs as potential biomarkers and therapeutic targets. Data are collected from Table 1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001615 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01001616 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001617 | Mitochondrion | HEK-293 cells|HeLa cells|Myotube | 27396686 |
| RLID:01001618 | Mitochondrion | HEK-293 cells|HeLa cells|Skeletal muscle cells | 27563705 |
| RLID:01001619 | Mitochondrion | Human umbilical vein endothelial cells | 30348904 |
| RLID:01001620 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001621 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001622 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001623 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:11001405 | Apoptotic body | Human umbilical vein endothelial cells | 19996457 |
| RLID:11001406 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11001407 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11001409 | Exosome | Plasma | 23663360 |
| RLID:11001410 | Exosome | Human esophageal cancer cell line (EC9706) | 25184951 |
| RLID:11001411 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11001412 | Microvesicle | Cerebrospinal fluid | 24797360 |
| RLID-D:11000049 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Kidney tissue|Lymphoma tissue|Mast cells|Tongue tissue | |
| RLID-D:11000318 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-181a-5p | Splenic marginal zone lymphoma | MNDR-E-MI-19501 |
| MNDR | hsa-miR-181a-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-19502 |
| MNDR | hsa-miR-181a-5p | Oral squamous cell carcinoma | MNDR-E-MI-19503 |
| MNDR | hsa-miR-181a-5p | Large cell neuroendocrine cancer | MNDR-E-MI-19504 |
| MNDR | hsa-miR-181a-5p | Medulloblastoma | MNDR-E-MI-19505 |
| MNDR | hsa-miR-181a-5p | Lymphoma | MNDR-E-MI-19506 |
| MNDR | hsa-miR-181a-5p | Lymphoma non-hodgkin | MNDR-E-MI-19507 |
| MNDR | hsa-miR-181a-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-19508 |
| MNDR | hsa-miR-181a-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-19509 |
| MNDR | hsa-miR-181a-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-19510 |
| MNDR | hsa-miR-181a-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-19511 |
| MNDR | hsa-miR-181a-5p | Her2-receptor positive breast cancer | MNDR-E-MI-19512 |
| MNDR | hsa-miR-181a-5p | Triple negative breast cancer | MNDR-E-MI-19513 |
| MNDR | hsa-miR-181a-5p | Breast cancer luminal | MNDR-E-MI-19514 |
| MNDR | hsa-miR-181a-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-19515 |
| MNDR | hsa-miR-181a-5p | Neurofibromatosis 1 | MNDR-E-MI-19516 |
| MNDR | hsa-miR-181a-5p | Prostate cancer | MNDR-E-MI-19517 |
| MNDR | hsa-miR-181a-5p | B-cell chronic lymphocytic leukemia | MNDR-E-MI-19518 |
| MNDR | hsa-miR-181a-5p | Gastric cancer | MNDR-E-MI-19519 |
| MNDR | hsa-miR-181a-5p | Gastric lymphoma | MNDR-E-MI-19520 |
| MNDR | hsa-miR-181a-5p | Alzheimer disease | MNDR-E-MI-19521 |
| MNDR | hsa-miR-181a-5p | Sickle cell anemia | MNDR-E-MI-19522 |
| MNDR | hsa-miR-181a-5p | Esophageal carcinoma | MNDR-E-MI-19523 |
| MNDR | hsa-miR-181a-5p | Dysautonomia familial | MNDR-E-MI-19524 |
| MNDR | hsa-miR-181a-5p | Head and neck cancer | MNDR-E-MI-19525 |
| MNDR | hsa-miR-181a-5p | Leukemia | MNDR-E-MI-19526 |
| MNDR | hsa-miR-181a-5p | Acute leukemia | MNDR-E-MI-19527 |
| MNDR | hsa-miR-181a-5p | Friedreich ataxia | MNDR-E-MI-19528 |
| MNDR | hsa-miR-181a-5p | Huntington disease | MNDR-E-MI-19529 |
| MNDR | hsa-miR-181a-5p | Chorea | MNDR-E-MI-19530 |
| MNDR | hsa-miR-181a-5p | Cardiovascular disease | MNDR-E-MI-19531 |
| MNDR | hsa-miR-181a-5p | Carotid stenosis | MNDR-E-MI-19532 |
| MNDR | hsa-miR-181a-5p | Lung cancer | MNDR-E-MI-19533 |
| MNDR | hsa-miR-181a-5p | Endometrial cancer | MNDR-E-MI-19534 |
| MNDR | hsa-miR-181a-5p | Down syndrome | MNDR-E-MI-19535 |
| MNDR | hsa-miR-181a-5p | Parkinson disease | MNDR-E-MI-19536 |
| MNDR | hsa-miR-181a-5p | Basal-like breast cancer | MNDR-E-MI-19537 |
| MNDR | hsa-miR-181a-5p | Neuroendocrine neoplasia | MNDR-E-MI-19538 |
| MNDR | hsa-miR-181a-5p | Thyroid cancer | MNDR-E-MI-19539 |
| MNDR | hsa-miR-181a-5p | Pancreatic cancer | MNDR-E-MI-19540 |
| MNDR | hsa-miR-181a-5p | Hepatitis C | MNDR-E-MI-19541 |
| MNDR | hsa-miR-181a-5p | Melanoma | MNDR-E-MI-19542 |
| MNDR | hsa-miR-181a-5p | Lesch-nyhan syndrome | MNDR-E-MI-19543 |
| MNDR | hsa-miR-181a-5p | Rectum adenocarcinoma | MNDR-E-MI-19544 |
| MNDR | hsa-miR-181a-5p | Nephroblastoma | MNDR-E-MI-19545 |
| MNDR | hsa-miR-181a-5p | Colon cancer | MNDR-E-MI-19546 |
| MNDR | hsa-miR-181a-5p | Ischemic attack transient | MNDR-E-MI-19547 |
| MNDR | hsa-miR-181a-5p | Colon adenocarcinoma | MNDR-E-MI-19548 |
| MNDR | hsa-miR-181a-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-19549 |
| MNDR | hsa-miR-181a-5p | Prostate adenocarcinoma | MNDR-E-MI-19550 |
| MNDR | hsa-miR-181a-5p | Cerebellar disease | MNDR-E-MI-19551 |
| MNDR | hsa-miR-181a-5p | Carcinoma ductal breast | MNDR-E-MI-19552 |
| MNDR | hsa-miR-181a-5p | Glioblastoma | MNDR-E-MI-19553 |
| MNDR | hsa-miR-181a-5p | Astrocytoma | MNDR-E-MI-19554 |
| MNDR | hsa-miR-181a-5p | Glioma | MNDR-E-MI-19555 |
| MNDR | hsa-miR-181a-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-19556 |
| MNDR | hsa-miR-181a-5p | Chordoma | MNDR-E-MI-19557 |
| MNDR | hsa-miR-181a-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-19558 |
| MNDR | hsa-miR-181a-5p | Liposarcoma | MNDR-E-MI-19559 |
| MNDR | hsa-miR-181a-5p | Coronary artery disease | MNDR-E-MI-19560 |
| MNDR | hsa-miR-181a-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-19561 |
| MNDR | hsa-miR-181a-5p | Meningioma | MNDR-E-MI-19562 |
| MNDR | hsa-miR-181a-5p | Hepatocellular cancer | MNDR-E-MI-19563 |
| MNDR | hsa-miR-181a-5p | Gastric adenocarcinoma | MNDR-E-MI-19564 |
| MNDR | hsa-miR-181a-5p | Cervical squamous cell carcinoma | MNDR-E-MI-19565 |
| MNDR | hsa-miR-181a-5p | Lung squamous cell carcinoma | MNDR-E-MI-19566 |
| MNDR | hsa-miR-181a-5p | Carcinoma lung non-small-cell | MNDR-E-MI-19567 |
| MNDR | hsa-miR-181a-5p | Lung adenocarcinoma | MNDR-E-MI-19568 |
| MNDR | hsa-miR-181a-5p | Thyroid carcinoma | MNDR-E-MI-19569 |
| MNDR | hsa-miR-181a-5p | Papillary thyroid carcinoma | MNDR-E-MI-19570 |
| MNDR | hsa-miR-181a-5p | Bladder urothelial carcinoma | MNDR-E-MI-19571 |
| MNDR | hsa-miR-181a-5p | Pancreatic adenocarcinoma | MNDR-E-MI-19572 |
| MNDR | hsa-miR-181a-5p | Cervical cancer | MNDR-E-MI-19573 |
| MNDR | hsa-miR-181a-5p | Carcinoma renal cell | MNDR-E-MI-19574 |
| MNDR | hsa-miR-181a-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-19575 |
| MNDR | hsa-miR-181a-5p | Clear cell renal cell carcinoma | MNDR-E-MI-19576 |
| MNDR | hsa-miR-181a-5p | Allergic rhinitis | MNDR-E-MI-19577 |
| MNDR | hsa-miR-181a-5p | Biliary tract cancer | MNDR-E-MI-19578 |
| MNDR | hsa-miR-181a-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-19579 |
| MNDR | hsa-miR-181a-5p | Cholangiocarcinoma | MNDR-E-MI-19580 |
| MNDR | hsa-miR-181a-5p | Pancreatitis | MNDR-E-MI-19581 |
| MNDR | hsa-miR-181a-5p | Esophageal cancer | MNDR-E-MI-19582 |
| MNDR | hsa-miR-181a-5p | Lung small cell carcinoma | MNDR-E-MI-19583 |
| MNDR | hsa-miR-181a-5p | Encephalopathy bovine spongiform | MNDR-E-MI-19584 |
| MNDR | hsa-miR-181a-5p | Synovial sarcoma | MNDR-E-MI-19585 |
| MNDR | hsa-miR-181a-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-19586 |
| MNDR | hsa-miR-181a-5p | T acute lymphoblastic leukemia | MNDR-E-MI-19587 |
| MNDR | hsa-miR-181a-5p | Encephalomyelitis | MNDR-E-MI-19588 |
| MNDR | hsa-miR-181a-5p | Breast invasive carcinoma | MNDR-E-MI-19589 |
| MNDR | hsa-miR-181a-5p | Hepatocellular carcinoma | MNDR-E-MI-19590 |
| MNDR | hsa-miR-181a-5p | Embryonal cancer | MNDR-E-MI-19591 |
| MNDR | hsa-miR-181a-5p | B-cell lymphoma | MNDR-E-MI-19592 |
| MNDR | hsa-miR-181a-5p | Rheumatoid arthritis | MNDR-E-MI-19593 |
| MNDR | hsa-miR-181a-5p | T-cell leukemia | MNDR-E-MI-19594 |
| MNDR | hsa-miR-181a-5p | Malignant pleural mesothelioma | MNDR-E-MI-19595 |
| MNDR | hsa-miR-181a-5p | Muscular atrophy | MNDR-E-MI-19596 |
| MNDR | hsa-miR-181a-5p | Retinoblastoma | MNDR-E-MI-19597 |
| MNDR | hsa-miR-181a-5p | Neuroblastoma | MNDR-E-MI-19598 |
| MNDR | hsa-miR-181a-5p | Chronic kidney disease | MNDR-E-MI-19599 |
| MNDR | hsa-miR-181a-5p | Influenza | MNDR-E-MI-19600 |
| MNDR | hsa-miR-181a-5p | Chronic myelogenous leukemia | MNDR-E-MI-19601 |
| MNDR | hsa-miR-181a-5p | Burkitt lymphoma | MNDR-E-MI-19602 |
| MNDR | hsa-miR-181a-5p | Myeloid leukemia | MNDR-E-MI-19603 |
| MNDR | hsa-miR-181a-5p | Neuromyelitis optica | MNDR-E-MI-19604 |
| MNDR | hsa-miR-181a-5p | Subacute sclerosing panencephalitis | MNDR-E-MI-19605 |
| MNDR | hsa-miR-181a-5p | Systemic lupus erythematosus | MNDR-E-MI-19606 |
| MNDR | hsa-miR-181a-5p | Acute myelocytic leukemia | MNDR-E-MI-19607 |
| MNDR | hsa-miR-181a-5p | Colorectal cancer | MNDR-E-MI-19608 |
| MNDR | hsa-miR-181a-5p | Multiple myeloma | MNDR-E-MI-19609 |
| MNDR | hsa-miR-181a-5p | Ependymoma | MNDR-E-MI-19610 |
| MNDR | hsa-miR-181a-5p | Graft vs host disease | MNDR-E-MI-19611 |
| MNDR | hsa-miR-181a-5p | Keloid | MNDR-E-MI-19612 |
| MNDR | hsa-miR-181a-5p | Prostatic neoplasms | MNDR-E-MI-19613 |
| MNDR | hsa-miR-181a-5p | Sleep deprivation | MNDR-E-MI-19614 |
| MNDR | hsa-miR-181a-5p | Aids dementia complex | MNDR-E-MI-19615 |
| MNDR | hsa-miR-181a-5p | Epstein-barr virus infections | MNDR-E-MI-19616 |
| MNDR | hsa-miR-181a-5p | Brain injury chronic | MNDR-E-MI-19617 |
| MNDR | hsa-miR-181a-5p | Gait ataxia | MNDR-E-MI-19618 |
| MNDR | hsa-miR-181a-5p | Stroke lacunar | MNDR-E-MI-19619 |
| MNDR | hsa-miR-181a-5p | Breast cancer her3+ negative | MNDR-E-MI-19620 |
| MNDR | hsa-miR-181a-5p | Cerebellar neurodegeneration | MNDR-E-MI-19621 |
| MNDR | hsa-miR-181a-5p | HPV | MNDR-E-MI-19622 |
| MNDR | hsa-miR-181a-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-19623 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCG2 | Homo sapiens | RR00024739 |
TOP